Zhejiang Wolwo Bio-Pharmaceutical: 300357 zhejiang wolwo bio-pharmaceutical Investor Relations Management Information 20240825
Zhejiang Wolwo Bio-Pharmaceutical: Announcement of the Supervisory Board's resolution.
Zhejiang Wolwo Bio-Pharmaceutical: The Management System of Shareholdings and Changes in Holdings of Directors, Supervisors, and Senior Management Personnel (August 2024).
Zhejiang Wolwo Bio-Pharmaceutical: Board of directors resolution announcement.
Zhejiang Wolwo Bio-Pharmaceutical: Investor Relations Activity Records for June 14, 2024.
Zhejiang Wolwo Bio-Pharmaceutical: Announcement of the Resolution of the Seventh Meeting of the Fifth Board of Directors.
Zhejiang Wolwo Bio-Pharmaceutical: Announcement regarding the change of General Manager of the company.
Zhejiang Wolwo Bio-Pharmaceutical: April 28, 2024 Investor Relations Activity Record Form (Results Briefing)
Wawu Biotech: Investor Relations Activity Record Form for April 19, 2024
Wawu Biotech: Special Explanation on Non-operating Capital Occupation and Other Related Capital Transactions
Wuwu Biotech: Announcement on holding the 2023 online performance briefing and soliciting related issues
Wawu Biotech: Announcement of Board Resolutions
Wuwu Biotech: Independent Director's 2023 Annual Debriefing Report-Zhang Feida (Zhang Feida)
Otake Biotech: 2023 Social Responsibility Report
Wawu Biotech: 2023 Annual Audit Report
Wawu Biotech: 2023 Supervisory Committee Work Report
We are martial arts: Supervisory Board Decision Announcement
Wowu Biotech: Board of Directors Special Opinions on the Independent Assessment of Sole Directors
WuWu Biology: Independent Director's 2023 Debriefing Report-Xu Guoliang
Wawu Biotech: Report on the work of the Board of Directors in 2023
No Data
No Data